WANDA SALYER: Open Payments
NPI 1578226502 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,421 in 70 payments from 15 companies in 2025. Trend: 2023 $514 · 2024 $592 · 2025 $1,421
Food & beverage: $1,421
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $191 |
| ABBVIE INC. | 10 | $152 |
| Otsuka America Pharmaceutical, Inc. | 6 | $129 |
| Alkermes, Inc. | 6 | $125 |
| Corium, LLC | 5 | $124 |
| Vanda Pharmaceuticals Inc. | 5 | $109 |
| Collegium Pharmaceutical, Inc. | 5 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $96 |
| Lundbeck LLC | 4 | $88 |
| Neurocrine BioSciences, Inc. | 3 | $81 |
Products named: CAPLYTA, REXULTI, VRAYLAR, ARISTADA, Azstarys, FANAPT, Jornay PM, TRINTELLIX.
Industry payments across GA — which companies pay providers there.
